about
The many faces of aire in central toleranceDendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantationGABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondiiβ-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKRCentral and overlapping role of Cathepsin B and inflammasome adaptor ASC in antigen presenting function of human dendritic cellsSaccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferationTolerogenic Dendritic Cells for Regulatory T Cell Induction in ManHow Neutrophils Shape Adaptive Immune ResponsesBiased and g protein-independent signaling of chemokine receptorsLocation, location, location: tissue-specific regulation of immune responsesSphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyondOral tolerance to food proteinPKCθ regulates T cell motility via ezrin-radixin-moesin localization to the uropodCCR4 promotes medullary entry and thymocyte-dendritic cell interactions required for central tolerance.Infection by Toxoplasma gondii Induces Amoeboid-Like Migration of Dendritic Cells in a Three-Dimensional Collagen MatrixNative cellulose nanofibrills induce immune tolerance in vitro by acting on dendritic cellsChemokine GPCR signaling inhibits β-catenin during zebrafish axis formationPriming by chemokines restricts lateral mobility of the adhesion receptor LFA-1 and restores adhesion to ICAM-1 nano-aggregates on human mature dendritic cellsRe-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infectionPrognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma.Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infectionsEffect of adhesion and chemokine presentation on T-lymphocyte haptokinesis.Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fieldsSolution Structure of CCL21 and Identification of a Putative CCR7 Binding SiteEmerging roles of lymphatic endothelium in regulating adaptive immunity.The Role of CC-Chemokines in the Regulation of AngiogenesisThe thymus and rheumatology: should we care?Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironmentMechanisms of Oral ToleranceVal-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumorsFusion of CCL21 non-migratory active breast epithelial and breast cancer cells give rise to CCL21 migratory active tumor hybrid cell linesAutoimmune regulator deficiency results in decreased expression of CCR4 and CCR7 ligands and in delayed migration of CD4+ thymocytesMucosal effects of tenofovir 1% gelCCR7 deficiency leads to leukocyte activation and increased clearance in response to pulmonary Pseudomonas aeruginosa infectionChemokine Receptor Ccr7 Restricts Fatal West Nile Virus EncephalitisThe dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed settingCharacteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain.Structural Evaluation and Binding Mode Analysis of CCL19 and CCR7 Proteins-Identification of Novel Leads for Rheumatic and Autoimmune Diseases: An Insilico study.Orai1 function is essential for T cell homing to lymph nodesSerum inflammatory mediators as markers of human Lyme disease activity.
P2860
Q21131201-94F04EA8-DB9A-48FC-B58B-93C5594389CDQ21284774-E3CE0084-2918-4F01-9ED0-081EAF43F5C3Q21558782-4D7BA1E2-ECD2-4BCB-AD33-6A246E6797AAQ24310522-13076C3A-2405-4D96-97EF-5367570D154FQ24338908-6A1705C3-F698-475F-B601-7D39D363CD78Q24654180-56548719-B387-45FA-8681-EA82CE102C81Q26776126-C47CA44B-0127-4323-9084-04679F3D2FE2Q26781286-8975A4A5-1BF0-443C-96D0-2262AA15A709Q26823970-075B65A1-9935-4F41-934A-D26503CE55F7Q27009106-8564BE00-1129-470F-86C3-CCF7B7E8BA70Q27011857-000C2F1A-BCFB-422F-9777-8426FBD7FCA2Q27026259-99563595-96F1-4F1B-874E-96E006BC7AA3Q27302947-1A2DAC69-750A-4F12-BD44-0AABF9CF6339Q27308795-D02580FF-9937-4B4B-BAEF-4A110D11BF3CQ27316204-42E23B2B-F8E7-43DE-8D8C-E017B76266C8Q27317032-610F6F51-078A-48ED-87F9-AECDBC7B2531Q27318670-9E0D1F5A-F11A-43D7-9BC2-F1E964FF78C8Q27324034-179D878B-7435-4C22-8CC9-D59C749223D9Q27331338-9041824F-44F0-449C-9DF0-65873CEA9E42Q27332109-889B8BE9-C595-4BD1-B03A-6CB6DA5BEC59Q27333255-DE69AB90-DC3B-4C6B-A2F4-F1ACCBAF9DCEQ27335954-71D7004F-B01F-406C-820B-FDB8B915F04FQ27349269-17BB3429-4B1F-4887-8ECD-75B4237EC28EQ27676570-27A478E1-4C16-4D00-A669-5390104C2A4DQ27686792-F3ADEDF6-CEB5-4369-8E46-10EAFC4DE816Q28077024-AAC50EED-EACF-48D0-AAD6-1185DE2C73B7Q28080019-4BD0088C-8C19-485F-A5E1-E105CFBF1F1BQ28081431-3A878B07-9BF9-499B-ADCF-9F70B9DA2270Q28082715-93A099C6-137C-4045-9AE7-2BC65AA333A0Q28395507-5C22EF19-477D-4E88-8AE5-5AF41DF0E151Q28487710-771B2755-AFD2-455F-9379-873B1926F188Q28512316-8DF468CA-B755-4CA4-A9CD-C6FDC694E7FFQ28545969-56755F6B-12BA-40A3-9292-BE60AEAA1961Q28586192-F1057CDF-B04C-40C5-A1D5-942EA48C7873Q29198018-BF87D4AC-4B09-407E-B433-73AF4EB8F38CQ29618424-B2BEFE68-984C-4AB1-AAF0-FF6492FEE3E5Q30354096-B9B59B64-E298-4EB2-A5DB-BC5982B2E747Q30399603-D2F6BB96-6C1A-45DC-A3F7-9885985FEEBFQ30538072-630706DE-3488-40A3-A6AD-05371EFC026CQ31158874-D78A0718-AEA9-4863-B4C7-87C38E46895C
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
CCR7 and its ligands: balancing immunity and tolerance
@ast
CCR7 and its ligands: balancing immunity and tolerance
@en
CCR7 and its ligands: balancing immunity and tolerance
@en-gb
CCR7 and its ligands: balancing immunity and tolerance
@nl
type
label
CCR7 and its ligands: balancing immunity and tolerance
@ast
CCR7 and its ligands: balancing immunity and tolerance
@en
CCR7 and its ligands: balancing immunity and tolerance
@en-gb
CCR7 and its ligands: balancing immunity and tolerance
@nl
prefLabel
CCR7 and its ligands: balancing immunity and tolerance
@ast
CCR7 and its ligands: balancing immunity and tolerance
@en
CCR7 and its ligands: balancing immunity and tolerance
@en-gb
CCR7 and its ligands: balancing immunity and tolerance
@nl
P921
P3181
P356
P1476
CCR7 and its ligands: balancing immunity and tolerance
@en
P2093
Ana Clara Davalos-Misslitz
P304
P3181
P356
10.1038/NRI2297
P407
P577
2008-05-01T00:00:00Z